Global Autacoids and Related Drugs Market Size, Status, Research and Forecast 2019

Published On: Sep 2019

Format: PDF

Publisher: QY Research

Pages: 99

Report ID: 60445

In 2018, the global Autacoids and Related Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Autacoids and Related Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autacoids and Related Drugs development in United States, Europe and China.

The key players covered in this study
Bedford Laboratories
Bristol-Myers Squibb
APP Pharma
Abbott Laboratories
Sanofi
Chattem
Xanodyne
AstraZeneca
Hospira

Market segment by Type, the product can be split into
Polypeptides
Decarboxylated Amino Acids
Eicosanoids

Market segment by Application, split into
Allergies
Inflammation
Gastric Acid Secretion
Neuroendocrine Regulation
Chronic Pain
Cardiovascular Diseases
Gastrointestinal Diseases

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Autacoids and Related Drugs status, future forecast, growth opportunity, key market and key players.
To present the Autacoids and Related Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Autacoids and Related Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Autacoids and Related Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Polypeptides
1.4.3 Decarboxylated Amino Acids
1.4.4 Eicosanoids
1.5 Market by Application
1.5.1 Global Autacoids and Related Drugs Market Share by Application (2014-2025)
1.5.2 Allergies
1.5.3 Inflammation
1.5.4 Gastric Acid Secretion
1.5.5 Neuroendocrine Regulation
1.5.6 Chronic Pain
1.5.7 Cardiovascular Diseases
1.5.8 Gastrointestinal Diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Autacoids and Related Drugs Market Size
2.2 Autacoids and Related Drugs Growth Trends by Regions
2.2.1 Autacoids and Related Drugs Market Size by Regions (2014-2025)
2.2.2 Autacoids and Related Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Autacoids and Related Drugs Market Size by Manufacturers
3.1.1 Global Autacoids and Related Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Autacoids and Related Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Autacoids and Related Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Autacoids and Related Drugs Key Players Head office and Area Served
3.3 Key Players Autacoids and Related Drugs Product/Solution/Service
3.4 Date of Enter into Autacoids and Related Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Autacoids and Related Drugs Market Size by Type (2014-2019)
4.2 Global Autacoids and Related Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Autacoids and Related Drugs Market Size (2014-2019)
5.2 Autacoids and Related Drugs Key Players in United States
5.3 United States Autacoids and Related Drugs Market Size by Type
5.4 United States Autacoids and Related Drugs Market Size by Application

6 Europe
6.1 Europe Autacoids and Related Drugs Market Size (2014-2019)
6.2 Autacoids and Related Drugs Key Players in Europe
6.3 Europe Autacoids and Related Drugs Market Size by Type
6.4 Europe Autacoids and Related Drugs Market Size by Application

7 China
7.1 China Autacoids and Related Drugs Market Size (2014-2019)
7.2 Autacoids and Related Drugs Key Players in China
7.3 China Autacoids and Related Drugs Market Size by Type
7.4 China Autacoids and Related Drugs Market Size by Application

8 Japan
8.1 Japan Autacoids and Related Drugs Market Size (2014-2019)
8.2 Autacoids and Related Drugs Key Players in Japan
8.3 Japan Autacoids and Related Drugs Market Size by Type
8.4 Japan Autacoids and Related Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Autacoids and Related Drugs Market Size (2014-2019)
9.2 Autacoids and Related Drugs Key Players in Southeast Asia
9.3 Southeast Asia Autacoids and Related Drugs Market Size by Type
9.4 Southeast Asia Autacoids and Related Drugs Market Size by Application

10 India
10.1 India Autacoids and Related Drugs Market Size (2014-2019)
10.2 Autacoids and Related Drugs Key Players in India
10.3 India Autacoids and Related Drugs Market Size by Type
10.4 India Autacoids and Related Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Autacoids and Related Drugs Market Size (2014-2019)
11.2 Autacoids and Related Drugs Key Players in Central & South America
11.3 Central & South America Autacoids and Related Drugs Market Size by Type
11.4 Central & South America Autacoids and Related Drugs Market Size by Application

12 International Players Profiles
12.1 Bedford Laboratories
12.1.1 Bedford Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Autacoids and Related Drugs Introduction
12.1.4 Bedford Laboratories Revenue in Autacoids and Related Drugs Business (2014-2019)
12.1.5 Bedford Laboratories Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Autacoids and Related Drugs Introduction
12.2.4 Bristol-Myers Squibb Revenue in Autacoids and Related Drugs Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 APP Pharma
12.3.1 APP Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Autacoids and Related Drugs Introduction
12.3.4 APP Pharma Revenue in Autacoids and Related Drugs Business (2014-2019)
12.3.5 APP Pharma Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Autacoids and Related Drugs Introduction
12.4.4 Abbott Laboratories Revenue in Autacoids and Related Drugs Business (2014-2019)
12.4.5 Abbott Laboratories Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Autacoids and Related Drugs Introduction
12.5.4 Sanofi Revenue in Autacoids and Related Drugs Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Chattem
12.6.1 Chattem Company Details
12.6.2 Company Description and Business Overview
12.6.3 Autacoids and Related Drugs Introduction
12.6.4 Chattem Revenue in Autacoids and Related Drugs Business (2014-2019)
12.6.5 Chattem Recent Development
12.7 Xanodyne
12.7.1 Xanodyne Company Details
12.7.2 Company Description and Business Overview
12.7.3 Autacoids and Related Drugs Introduction
12.7.4 Xanodyne Revenue in Autacoids and Related Drugs Business (2014-2019)
12.7.5 Xanodyne Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Autacoids and Related Drugs Introduction
12.8.4 AstraZeneca Revenue in Autacoids and Related Drugs Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Hospira
12.9.1 Hospira Company Details
12.9.2 Company Description and Business Overview
12.9.3 Autacoids and Related Drugs Introduction
12.9.4 Hospira Revenue in Autacoids and Related Drugs Business (2014-2019)
12.9.5 Hospira Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details